• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ADVANIX BILIARY; CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ADVANIX BILIARY; CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Model Number M00534350
Device Problems Obstruction of Flow (2423); Migration (4003)
Patient Problem Fatigue (1849)
Event Date 06/16/2021
Event Type  Injury  
Manufacturer Narrative
Patient's exact age is unknown; however, it was reported that the patient's year of birth was 1968.
 
Event Description
This report is one of two complaints that pertain to the same event (mfr.Report #3005099803-2022-07113).It was reported to boston scientific corporation that an advanix biliary stent was used during an endoscopic retrograde cholangiopancreatography procedure in the common bile duct, performed on (b)(6) 2021.Post procedure, the patient was admitted to the hospital for further workup.The patient was treated with zosyn for suspected cholangitis.The patient had a ct-scan in the emergency department, and it showed that the stent migrated from the right portal biliary duct into the common bile duct.On (b)(6) 2021, an ercp procedure was performed for stent removal.During the procedure, it was noted that two stents migrated and were obstructed.Both stents were successfully removed in this procedure.It was reported that two stents, one of the same model and other of a different model were successfully placed and have completed the procedure.On the following day, post procedure, the patient had experienced a slight increased abdominal pain.The increased fatigue was suspected to be secondary to the procedure versus acute pancreatitis.The condition of the patient was reported to have improved and was discharged.Discharge medication of oral levofloxacin and flagyl antibiotics were prescribed to the patient for a total of ten-day course.It was reported that there was no connection of the stent and the cholangitis, however, the patient improved after stent removal and antibiotics.On (b)(6) 2021, the stents that were placed on (b)(6) 2021 were removed.It was noticed that the stents had partially migrated.There were no new stents replaced after stent removal.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANIX BILIARY
Type of Device
CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
780 brookside drive
spencer IN 47460
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key15941014
MDR Text Key305078250
Report Number3005099803-2022-06992
Device Sequence Number1
Product Code FGE
UDI-Device Identifier08714729787440
UDI-Public08714729787440
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K101314
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/08/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/22/2022
Device Model NumberM00534350
Device Catalogue Number3435
Device Lot Number0026061692
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/07/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/22/2020
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexMale
Patient Weight24 KG
-
-